
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE49D689B776F31B49D6000A758322.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332155/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy">
<meta name="citation_author" content="Yong Zhang">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Chaoji Zhang">
<meta name="citation_author_institution" content="Department of Cardiac Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730 China">
<meta name="citation_author" content="Peng Qin">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Baozhen Ma">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Anqi Lyu">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Fang Zhang">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Tiepeng Li">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Lu Han">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Yiman Shang">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Zibing Wang">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Quanli Gao">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_author" content="Lingdi Zhao">
<meta name="citation_author_institution" content="Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="28995">
<meta name="citation_doi" content="10.1038/s41598-025-14110-z">
<meta name="citation_pmid" content="40775000">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332155/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332155/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332155/pdf/41598_2025_Article_14110.pdf">
<meta name="description" content="Neoadjuvant chemoimmunotherapy has transformed the treatment of locally advanced gastric or gastroesophageal junction (G/GEJ) cancer. However, identifying reliable predictive markers for treatment efficacy remains challenging. We conducted a ...">
<meta name="og:title" content="Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Neoadjuvant chemoimmunotherapy has transformed the treatment of locally advanced gastric or gastroesophageal junction (G/GEJ) cancer. However, identifying reliable predictive markers for treatment efficacy remains challenging. We conducted a ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332155/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12332155">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41598-025-14110-z"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41598_2025_Article_14110.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332155%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12332155/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12332155/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332155/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2025 Aug 8;15:28995. doi: <a href="https://doi.org/10.1038/s41598-025-14110-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41598-025-14110-z</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Impact of Tregs on tumor regression in locally advanced G/GEJ cancer patients undergoing neoadjuvant chemoimmunotherapy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yong Zhang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yong Zhang</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yong Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Chaoji Zhang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Chaoji Zhang</span></h3>
<div class="p">
<sup>2</sup>Department of Cardiac Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chaoji Zhang</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qin%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Peng Qin</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Peng Qin</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qin%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peng Qin</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Baozhen Ma</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Baozhen Ma</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Baozhen Ma</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lyu%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Anqi Lyu</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Anqi Lyu</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lyu%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anqi Lyu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Fang Zhang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Fang Zhang</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fang Zhang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Tiepeng Li</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Tiepeng Li</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tiepeng Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Lu Han</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Lu Han</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lu Han</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yiman Shang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yiman Shang</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yiman Shang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Zibing Wang</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Zibing Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zibing Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gao%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Quanli Gao</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Quanli Gao</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gao%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Quanli Gao</span></a>
</div>
</div>
<sup>1,</sup><sup>âœ‰</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Lingdi Zhao</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Lingdi Zhao</span></h3>
<div class="p">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lingdi Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University &amp; Henan Cancer Hospital, Zhengzhou City, 450008 China </div>
<div id="Aff2">
<sup>2</sup>Department of Cardiac Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730 China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Aug 30; Accepted 2025 Jul 29; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the articleâ€™s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12332155Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40775000/" class="usa-link">40775000</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Neoadjuvant chemoimmunotherapy has transformed the treatment of locally advanced gastric or gastroesophageal junction (G/GEJ) cancer. However, identifying reliable predictive markers for treatment efficacy remains challenging. We conducted a retrospective analysis to evaluate the prognostic value of peripheral blood regulatory T (Treg) cells in patients with G/GEJ cancer undergoing neoadjuvant chemoimmunotherapy followed by curative resection. From July 2020 to May 2023, 79 patients met the inclusion criteria. All patients achieved R0 resection following D2 radical surgery, with 26.6% exhibiting a pathological complete response (pCR). Significant differences in Treg cells, T/Treg ratios, and CD4+/Treg ratios were observed between patients with pCR and those without after one treatment cycle (<em>P</em> = 0.0054, 0.0489, and 0.0434, respectively). Patients were categorized based on changes in Treg cell counts post-treatment, revealing a higher pCR rate in those with reduced Treg cells (<em>P</em> = 0.014). Changes in Treg cell counts after one cycle of neoadjuvant chemoimmunotherapy serve as a promising predictive marker for pCR in locally advanced G/GEJ cancer patients. This finding supports the development of personalized treatment strategies, enhancing outcomes in this challenging clinical landscape.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1038/s41598-025-14110-z.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Neoadjuvant chemoimmunotherapy, Gastric or gastroesophageal junction cancer, Regulatory T cells, Predictive markers, Personalized treatment</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Subject terms:</strong> Gastroenterology, Oncology</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">In the realm of oncology, the introduction of immunotherapy has markedly transformed the treatment landscape for various cancers, including gastric and gastroesophageal junction (G/GEJ) cancers. These malignancies represent a significant global health challenge, contributing extensively to cancer-related morbidity and mortality<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. Despite advancements in diagnostic and therapeutic techniques, the prognosis for patients with locally advanced G/GEJ cancers remains poor, underscoring the urgent need for innovative therapeutic approaches to improve patient outcomes.</p>
<p id="Par3">Neoadjuvant chemotherapy has become fundamental in managing these cancers, aiming at tumor reduction and the elimination of micrometastases prior to surgical intervention<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>. This strategy lays the groundwork for more successful surgical outcomes, increasing the likelihood of complete tumor resection. The emergence of immune checkpoint inhibitors, especially targeting the programmed death-1 (PD-1) pathway, have been effectively incorporated into neoadjuvant protocols, offering new hope for enhancing patient survival<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>.</p>
<p id="Par4">The incorporation of immune checkpoint inhibitors, especially those targeting the PD-1 pathway, into neoadjuvant chemoimmunotherapy leverages the synergistic effects of these modalities to enhance tumor reduction and potentially improve survival rates. This strategy marks a paradigm shift in the management of G/GEJ cancers, aiming to recalibrate the bodyâ€™s immune response against cancer cells<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>. However, the therapeutic landscape of neoadjuvant chemoimmunotherapy is complex, characterized by significant variability in patient responses. This variability highlights the intricate interactions between cancer and the immune system. Some patients may achieve a pathological complete response (pCR), indicating no detectable cancer cells post-treatment, which is associated with favorable long-term outcomes<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>â€“<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>. The occurrence of pCR underscores the potential efficacy of neoadjuvant chemoimmunotherapy but also emphasizes the urgent need for reliable biomarkers to predict treatment success.</p>
<p id="Par5">A key area of research is the immunological milieu within the tumor microenvironment, particularly the role of regulatory T cells (Tregs) in influencing the effectiveness of neoadjuvant therapies. This introduction explores the dynamics of Tregs in the context of neoadjuvant PD-1 antibody treatment in patients with locally advanced G/GEJ cancers, focusing on their impact on pCR rates post-surgery. In the pursuit of personalized medicine, identifying predictive markers is essential. These markers are crucial for tailoring treatment plans that optimize therapeutic efficacy and minimize adverse effects for patients unlikely to benefit.</p>
<p id="Par6">Within the immune landscape, Tregs, a specialized subset of CD4 + T cells, play a central role<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>,<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>. Tregs, through their immunosuppressive capabilities, maintain immune homeostasis by orchestrating the bodyâ€™s response to both internal and external threats, including cancer<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>. The interplay between effector immune cells and Tregs within the tumor microenvironment critically influences cancer progression and responses to immunotherapy<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>,<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. This balance may either promote tumor progression by enabling immune evasion or enhance the effectiveness of immunotherapy by modifying the immune milieu<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup>. Consequently, modulating Treg activity has become a promising target in cancer immunotherapy. Elucidating the role of Tregs in neoadjuvant chemoimmunotherapy for G/GEJ cancer offers the potential to uncover new insights into the mechanisms driving treatment response and resistance.</p>
<p id="Par7">This study investigates the dynamics of peripheral blood Tregs as a prognostic tool for assessing the efficacy of neoadjuvant chemoimmunotherapy in patients with locally advanced G/GEJ cancer. By examining lymphocyte subpopulations before and after one therapy cycle, our research aims to elucidate the relationship between Tregs and clinical outcomes, particularly in achieving pCR. Given the complex interplay between the immune system and cancer progression, our study contributes to refining cancer treatment precision by tailoring strategies to the unique immunological profiles of individual patients. Additionally, this research sheds light on the immunological underpinnings of treatment responses, potentially opening new avenues for therapeutic innovation. By delineating the intricate interactions between immune cells and cancer cells, we aim to develop novel strategies to combat G/GEJ malignancies, thereby enriching the therapeutic arsenal against this challenging disease. Through these efforts, we seek to advance the scientific understanding of cancer immunotherapy and foster the development of more effective, personalized treatment modalities, ultimately enhancing patient outcomes in G/GEJ cancers.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec9"><h3 class="pmc_sec_title">Patient characteristics</h3>
<p id="Par9">Between July 1, 2020, and May 31, 2023, a total of 79 patients with locally advanced gastric/gastroesophageal junction (G/GEJ) cancer who underwent neoadjuvant chemoimmunotherapy were enrolled in this study. The inclusion criteria for patient selection are comprehensively detailed in the â€œ<a href="#Sec4" class="usa-link">Materials and methods</a>â€ Section.</p>
<p id="Par10">Patients were stratified into two groups based on their pathological response post-surgery: the pCR group and the non-pCR group. The pCR group consisted of 21 patients, while the non-pCR group comprised 58 patients. The baseline characteristics of both groups are summarized in TableÂ <a href="#Tab1" class="usa-link">1</a>. As illustrated in TableÂ <a href="#Tab1" class="usa-link">1</a>, aside from differences in the interval between the final cycle of neoadjuvant therapy and surgery and PD-L1 CPS expression, no other characteristics exhibited statistically significant differences between the two groups.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Baseline characteristics of patients.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">pCR</th>
<th align="left" colspan="1" rowspan="1">Non-pCR</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Gender (male/female)</td>
<td align="left" colspan="1" rowspan="1">20/1</td>
<td align="left" colspan="1" rowspan="1">46/12</td>
<td align="center" colspan="1" rowspan="1">0.1667</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age (mean Â± SD)</td>
<td align="left" colspan="1" rowspan="1">60 Â± 6</td>
<td align="left" colspan="1" rowspan="1">60 Â± 8</td>
<td align="center" colspan="1" rowspan="1">0.8253</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ECOG (0/1)</td>
<td align="left" colspan="1" rowspan="1">13/8</td>
<td align="left" colspan="1" rowspan="1">23/35</td>
<td align="center" colspan="1" rowspan="1">0.1241</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BMI (mean Â± SD)</td>
<td align="left" colspan="1" rowspan="1">22.34 Â± 2.98</td>
<td align="left" colspan="1" rowspan="1">23.89 Â± 3.31</td>
<td align="center" colspan="1" rowspan="1">0.0653</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical T (T3/T4)</td>
<td align="left" colspan="1" rowspan="1">9/12</td>
<td align="left" colspan="1" rowspan="1">35/23</td>
<td align="center" colspan="1" rowspan="1">0.2043</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical N (N+/N-)</td>
<td align="left" colspan="1" rowspan="1">21/0</td>
<td align="left" colspan="1" rowspan="1">55/3</td>
<td align="center" colspan="1" rowspan="1">0.5769</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tumor location</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.2973</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Â Gastric body</td>
<td align="left" colspan="1" rowspan="1">17</td>
<td align="left" colspan="1" rowspan="1">40</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Â Gastroesophageal junction</td>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Her2 overexpression<sup>Â§</sup>
</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">15</td>
<td align="center" colspan="1" rowspan="1">&gt; 0.9999</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PD-L1 CPS (â‰¥ 1 / &lt;1)<sup>#</sup>
</td>
<td align="left" colspan="1" rowspan="1">14/4</td>
<td align="left" colspan="1" rowspan="1">23/26</td>
<td align="center" colspan="1" rowspan="1">0.0293</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Albumin (mean Â± SD)</td>
<td align="left" colspan="1" rowspan="1">39.7 Â± 5.0</td>
<td align="left" colspan="1" rowspan="1">41.7 Â± 4.9</td>
<td align="center" colspan="1" rowspan="1">0.1142</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chemotherapeutic regimen (FLOT/CAPOX)</td>
<td align="left" colspan="1" rowspan="1">16/5</td>
<td align="left" colspan="1" rowspan="1">45/13</td>
<td align="center" colspan="1" rowspan="1">0.8961</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Days between surgery and the last neoadjuvant therapy</td>
<td align="left" colspan="1" rowspan="1">37 Â± 7</td>
<td align="left" colspan="1" rowspan="1">28 Â± 10</td>
<td align="center" colspan="1" rowspan="1">0.009</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Duration of surgery (mean Â± SD, min)</td>
<td align="left" colspan="1" rowspan="1">236 Â± 56</td>
<td align="left" colspan="1" rowspan="1">232 Â± 60</td>
<td align="center" colspan="1" rowspan="1">0.7666</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">No. of nodes examined (median, range)</td>
<td align="left" colspan="1" rowspan="1">29 (12â€“56)</td>
<td align="left" colspan="1" rowspan="1">26 (15â€“58)</td>
<td align="center" colspan="1" rowspan="1">0.9960</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p13">
<p><sup>Â§</sup>The Her2 status was unavailable in one patients with non-pCR.</p>
<p><sup>#</sup>The status of PD-L1 CPS was unavailable in three patients with pCR and nine patients with non-pCR.</p>
</div></div></section></section><section id="Sec7"><h3 class="pmc_sec_title">Lymphocyte subgroups at baseline</h3>
<p id="Par13">We measured the counts of lymphocytes, monocytes, T cells, B cells, CD3 + CD4 + cells, CD3 + CD8 + cells, and Tregs in the peripheral blood of patients prior to treatment. Using the independent samples t-test, we found no statistically significant differences in Treg counts between the pCR group and the non-pCR group (TableÂ <a href="#Tab2" class="usa-link">2</a>; Fig.Â <a href="#Fig1" class="usa-link">1</a>A). Further comparative analysis of T/Treg ratios, CD4 + T/Treg, and CD8 + T/Treg ratios also showed no statistically significant differences between the two patient groups (TableÂ <a href="#Tab2" class="usa-link">2</a>, Fig. S1A, D, G).</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Comparison of lymphocyte subgroup at baseline (/dL).</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">pCR</th>
<th align="left" colspan="1" rowspan="1">Non-pCR</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Lymphocyte</td>
<td align="center" colspan="1" rowspan="1">1700 Â± 656</td>
<td align="center" colspan="1" rowspan="1">1753 Â± 620</td>
<td align="center" colspan="1" rowspan="1">0.6546</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Monocyte</td>
<td align="center" colspan="1" rowspan="1">313 Â± 84</td>
<td align="center" colspan="1" rowspan="1">334 Â± 136</td>
<td align="center" colspan="1" rowspan="1">0.5079</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T lymphocyte</td>
<td align="center" colspan="1" rowspan="1">1180 Â± 465</td>
<td align="center" colspan="1" rowspan="1">1211 Â± 458</td>
<td align="center" colspan="1" rowspan="1">0.7946</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">B lymphocyte</td>
<td align="center" colspan="1" rowspan="1">156 Â± 91</td>
<td align="center" colspan="1" rowspan="1">173 Â± 113</td>
<td align="center" colspan="1" rowspan="1">0.532</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NK cell</td>
<td align="center" colspan="1" rowspan="1">342 Â± 226</td>
<td align="center" colspan="1" rowspan="1">349 Â± 260</td>
<td align="center" colspan="1" rowspan="1">0.9085</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD3CD4 cell</td>
<td align="center" colspan="1" rowspan="1">697 Â± 342</td>
<td align="center" colspan="1" rowspan="1">701 Â± 304</td>
<td align="center" colspan="1" rowspan="1">0.9621</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD3CD8 cell</td>
<td align="center" colspan="1" rowspan="1">389 Â± 166</td>
<td align="center" colspan="1" rowspan="1">399 Â± 193</td>
<td align="center" colspan="1" rowspan="1">0.8281</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treg</td>
<td align="center" colspan="1" rowspan="1">61 Â± 32</td>
<td align="center" colspan="1" rowspan="1">63 Â± 32</td>
<td align="center" colspan="1" rowspan="1">0.8135</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T/Treg</td>
<td align="center" colspan="1" rowspan="1">21.5 Â± 7.9</td>
<td align="center" colspan="1" rowspan="1">22.1 Â± 8.9</td>
<td align="center" colspan="1" rowspan="1">0.8109</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD4+/Treg</td>
<td align="center" colspan="1" rowspan="1">11.9 Â± 3.2</td>
<td align="center" colspan="1" rowspan="1">11.9 Â± 3.0</td>
<td align="center" colspan="1" rowspan="1">0.9742</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD8/Treg</td>
<td align="center" colspan="1" rowspan="1">7.7 Â± 4.9</td>
<td align="center" colspan="1" rowspan="1">8.0 Â± 5.8</td>
<td align="center" colspan="1" rowspan="1">0.8232</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332155_41598_2025_14110_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8971/12332155/2e62439287fa/41598_2025_14110_Fig1_HTML.jpg" loading="lazy" id="d33e641" height="130" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Dynamics of Treg Cells During Treatment. (<strong>A</strong>) Treg cell counts at baseline between the two groups, demonstrating no significant statistical difference. (<strong>B</strong>) Treg cell counts before the second cycle of therapy, illustrating a statistically significant disparity in Treg cell counts between patients achieving pathological complete response (pCR) and those not achieving pCR. (<strong>C</strong>) Changes in Treg cell counts after one cycle of neoadjuvant chemoimmunotherapy, revealing a decrease in Treg cell counts in patients who achieved pCR.</p></figcaption></figure></section><section id="Sec50"><h3 class="pmc_sec_title">Lymphocyte subgroups after one cycle of neoadjuvant therapy</h3>
<p id="Par17">Following one cycle of neoadjuvant chemoimmunotherapy, we conducted a statistical analysis of the counts of lymphocytes, monocytes, T lymphocytes, B lymphocytes, CD3 + CD4 + cells, CD3 + CD8 + cells, and Tregs in the patientsâ€™ peripheral blood. The independent samples t-test revealed statistically significant differences in Tregs between the pCR and non-pCR groups, specifically in the levels of T lymphocytes and Tregs (TableÂ <a href="#Tab3" class="usa-link">3</a>; Fig.Â <a href="#Fig1" class="usa-link">1</a>B). Further comparative analyses of the T/Treg, CD4 + T/Treg, and CD8 + T/Treg ratios indicated that the differences in ratios between the groups were also statistically significant (TableÂ <a href="#Tab3" class="usa-link">3</a>, Fig. S1B, E, H), highlighting the potential immunological markers of response to therapy.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Comparison of lymphocyte subgroup before the second cycle of neoadjuvant therapy (/dL).</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">pCR</th>
<th align="left" colspan="1" rowspan="1">Non-pCR</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Lymphocyte</td>
<td align="center" colspan="1" rowspan="1">1577 Â± 466</td>
<td align="center" colspan="1" rowspan="1">1811 Â± 563</td>
<td align="center" colspan="1" rowspan="1">0.0935</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Monocyte</td>
<td align="center" colspan="1" rowspan="1">549 Â± 371</td>
<td align="center" colspan="1" rowspan="1">509 Â± 260</td>
<td align="center" colspan="1" rowspan="1">0.5967</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T lymphocyte</td>
<td align="center" colspan="1" rowspan="1">1083 Â± 286</td>
<td align="center" colspan="1" rowspan="1">1289 Â± 360</td>
<td align="center" colspan="1" rowspan="1">0.0206</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">B lymphocyte</td>
<td align="center" colspan="1" rowspan="1">122 Â± 80</td>
<td align="center" colspan="1" rowspan="1">147 Â± 95</td>
<td align="center" colspan="1" rowspan="1">0.2881</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NK cell</td>
<td align="center" colspan="1" rowspan="1">353 Â± 235</td>
<td align="center" colspan="1" rowspan="1">353 Â± 259</td>
<td align="center" colspan="1" rowspan="1">0.9923</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD3CD4 cell</td>
<td align="center" colspan="1" rowspan="1">624 Â± 210</td>
<td align="center" colspan="1" rowspan="1">737 Â± 238</td>
<td align="center" colspan="1" rowspan="1">0.0590</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD3CD8 cell</td>
<td align="center" colspan="1" rowspan="1">362 Â± 128</td>
<td align="center" colspan="1" rowspan="1">423 Â± 175</td>
<td align="center" colspan="1" rowspan="1">0.1497</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treg</td>
<td align="center" colspan="1" rowspan="1">48 Â± 26</td>
<td align="center" colspan="1" rowspan="1">66 Â± 32</td>
<td align="center" colspan="1" rowspan="1">0.0054</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T/Treg</td>
<td align="center" colspan="1" rowspan="1">29.2 Â± 17.5</td>
<td align="center" colspan="1" rowspan="1">23.7 Â± 12.4</td>
<td align="center" colspan="1" rowspan="1">0.0489</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD4+/Treg</td>
<td align="center" colspan="1" rowspan="1">16.3 Â± 9.7</td>
<td align="center" colspan="1" rowspan="1">13.2 Â± 6.6</td>
<td align="center" colspan="1" rowspan="1">0.0434</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD8/Treg</td>
<td align="center" colspan="1" rowspan="1">10.3 Â± 7.7</td>
<td align="center" colspan="1" rowspan="1">8.1 Â± 5.8</td>
<td align="center" colspan="1" rowspan="1">0.0886</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec51"><h3 class="pmc_sec_title">Changes in lymphocyte subgroups after one cycle of neoadjuvant therapy</h3>
<p id="Par20">After a single cycle of neoadjuvant chemoimmunotherapy, we calculated and compared the changes in lymphocyte subpopulations (by subtracting the counts of lymphocyte subpopulations before the second cycle from those before the first cycle of treatment). The results demonstrated statistically significant differences in the changes in Tregs between the pCR group and the non-pCR group (TableÂ <a href="#Tab4" class="usa-link">4</a>; Fig.Â <a href="#Fig1" class="usa-link">1</a>C). In the pCR group, Tregs levels decreased after one cycle of neoadjuvant chemoimmunotherapy, whereas in the non-pCR group, Tregs levels increased following the initial cycle of treatment.</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Comparison the changes of lymphocyte subgroup from the second cycle of neoadjuvant therapy to baseline (/dL).</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">pCR</th>
<th align="left" colspan="1" rowspan="1">Non-pCR</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Lymphocyte</td>
<td align="center" colspan="1" rowspan="1">-123 Â± 749</td>
<td align="center" colspan="1" rowspan="1">58 Â± 589</td>
<td align="center" colspan="1" rowspan="1">0.2669</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Monocyte</td>
<td align="center" colspan="1" rowspan="1">236 Â± 339</td>
<td align="center" colspan="1" rowspan="1">175 Â± 286</td>
<td align="center" colspan="1" rowspan="1">0.4304</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T lymphocyte</td>
<td align="center" colspan="1" rowspan="1">-97 Â± 482</td>
<td align="center" colspan="1" rowspan="1">79 Â± 429</td>
<td align="center" colspan="1" rowspan="1">0.1240</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">B lymphocyte</td>
<td align="center" colspan="1" rowspan="1">-33 Â± 51</td>
<td align="center" colspan="1" rowspan="1">-26 Â± 73</td>
<td align="center" colspan="1" rowspan="1">0.6566</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NK cell</td>
<td align="center" colspan="1" rowspan="1">11 Â± 280</td>
<td align="center" colspan="1" rowspan="1">4 Â± 120</td>
<td align="center" colspan="1" rowspan="1">0.9056</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD3CD4 cell</td>
<td align="center" colspan="1" rowspan="1">-73 Â± 311</td>
<td align="center" colspan="1" rowspan="1">36 Â± 279</td>
<td align="center" colspan="1" rowspan="1">0.1423</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD3CD8 cell</td>
<td align="center" colspan="1" rowspan="1">-27 Â± 142</td>
<td align="center" colspan="1" rowspan="1">23 Â± 152</td>
<td align="center" colspan="1" rowspan="1">0.1881</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treg</td>
<td align="center" colspan="1" rowspan="1">-13 Â± 35</td>
<td align="center" colspan="1" rowspan="1">3 Â± 28</td>
<td align="center" colspan="1" rowspan="1">0.0063</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T/Treg</td>
<td align="center" colspan="1" rowspan="1">7.7 Â± 13.6</td>
<td align="center" colspan="1" rowspan="1">1.7 Â± 9.0</td>
<td align="center" colspan="1" rowspan="1">0.0055</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD4/Treg</td>
<td align="center" colspan="1" rowspan="1">4.4 Â± 9.0</td>
<td align="center" colspan="1" rowspan="1">1.4 Â± 6.0</td>
<td align="center" colspan="1" rowspan="1">0.0664</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD8/Treg</td>
<td align="center" colspan="1" rowspan="1">2.6 Â± 4.4</td>
<td align="center" colspan="1" rowspan="1">0.1 Â± 3.3</td>
<td align="center" colspan="1" rowspan="1">0.0013</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par22">In our study, we conducted a detailed comparison of the changes in T/Treg ratios, CD4 + T/Treg ratios, and CD8 + T/Treg ratios after one cycle of neoadjuvant chemoimmunotherapy. We found that, following one treatment cycle, the differences in T/Treg ratios and CD8 + T/Treg ratios between the pCR group and the non-pCR group were statistically significant (TableÂ <a href="#Tab4" class="usa-link">4</a>, Fig. S1C, F, I).</p></section><section id="Sec52"><h3 class="pmc_sec_title">Correlation of Treg cell changes with pCR rates</h3>
<p id="Par24">After one cycle of neoadjuvant chemoimmunotherapy, an increase in Treg cells was observed in 37 patients, of whom 5 achieved a pCR, resulting in a pCR rate of 13.5% (95% Confidence Interval [CI]: 2.0-25.1%). Conversely, among the 42 patients who experienced a decrease in Treg cells, 16 achieved a pCR, marking a pCR rate of 38.1% (95% CI: 22.8â€“53.4%). Statistical analysis revealed a significant difference in pCR rates between the groups with increased and decreased Tregs (<em>P</em> = 0.014).</p></section><section id="Sec53"><h3 class="pmc_sec_title">Disease-free survival</h3>
<p id="Par26">As of the last follow-up date on December 31, 2023, the average follow-up period was 20.9 months (95% confidence interval: 19.2â€“22.7 months). The median DFS and OS have not yet been reached for the patients. The DFS and OS curves for all patients are displayed in Fig.Â <a href="#Fig2" class="usa-link">2</a>A. Within the group achieving pCR, there was one case of recurrence, with the affected patient still alive at the last follow-up. In the non-pCR group, there were 16 recurrences and 10 deaths. Although the median DFS for both the pCR and non-pCR groups has not been reached, survival analysis revealed a statistically significant difference in DFS between the two groups (<em>P</em> = 0.0245) (Fig.Â <a href="#Fig2" class="usa-link">2</a>B).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12332155_41598_2025_14110_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8971/12332155/cd141ca4ad6f/41598_2025_14110_Fig2_HTML.jpg" loading="lazy" id="d33e959" height="155" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Survival Analysis. (<strong>A</strong>) Kaplan-Meier curves illustrating Disease-Free Survival (DFS) and Overall Survival (OS) for all patients enrolled in this study. (<strong>B</strong>) DFS stratified by tumor regression. Patients achieving pathological complete response (pCR) demonstrated significantly prolonged median DFS compared to non-pCR counterparts. (<strong>C</strong>) DFS stratified by changes in Treg cell counts following one cycle of neoadjuvant chemoimmunotherapy. Patients experiencing decreased Treg cell counts exhibited extended DFS compared to those with elevated Treg cell counts.</p></figcaption></figure><p id="Par28">Patients were also categorized into groups with increased or decreased Tregs following one cycle of neoadjuvant chemoimmunotherapy. There were 12 recurrences in the increased Treg group compared to 5 in the decreased Treg group, showing a statistically significant difference in DFS between these groups (<em>P</em> = 0.0067) (Fig.Â <a href="#Fig2" class="usa-link">2</a>C).</p>
<p id="Par29">We conducted a subgroup analysis of DFS based on the expression of PD-L1 Combined Positive Score (CPS) and Her2 expression in pre-operative biopsy specimens, as well as post-operative lymph node involvement. Our findings revealed that the differences in DFS between subgroups with PD-L1 CPS &lt; 1 and â‰¥ 1, as well as those with Her2 overexpression or not, did not reach statistical significance (for specific P values, refer to Figs. S2A and B). However, when patients were categorized into pN positive (with residual tumor) and pN negative (without residual tumor) groups based on post-operative lymph node status, a statistically significant difference in DFS was observed between these two groups (<em>P</em> = 0.0011) (Fig. S2C).</p></section></section><section id="Sec3"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par30">Our study reveals significant insights into the dynamics of Treg cells during neoadjuvant chemoimmunotherapy in G/GEJ cancer, highlighting their correlation with post-surgical pCR rates. We observed that an increase in Treg cells after one cycle of treatment correlates with a lower pCR rate, while a decrease suggests better outcomes. This underscores the dual role of Tregs; although essential for immune balance and preventing autoimmunity, their immunosuppressive functions can impede effective antitumor responses, thereby influencing the efficacy of neoadjuvant treatments in G/GEJ cancers. These findings align with previous research indicating that Tregs can promote tumor growth by suppressing antitumor immunity, corroborating our observations of improved treatment outcomes following Treg reduction<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>,<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>.</p>
<p id="Par31">As shown in TableÂ <a href="#Tab1" class="usa-link">1</a>, apart from the differences in baseline PD-L1 expression and the interval between the last dose of neoadjuvant therapy and surgery, other baseline characteristics between the pCR and non-pCR groups are comparable. CM649 and Orient16 have confirmed that PD-L1 CPS expression is an indicator of whether patients with advanced gastric and gastroesophageal junction cancer benefit from first-line chemotherapy and immunotherapy combination<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>,<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. Similar results have been found in clinical studies on neoadjuvant chemotherapy and immunotherapy for gastric cancer<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>. The results of this study are consistent with these published findings, as patients with PD-L1 CPS â‰¥ 1 are more likely to achieve pCR when treated with neoadjuvant chemotherapy and immunotherapy. A longer interval between the last dose of neoadjuvant chemotherapy and surgery may provide activated lymphocytes with sufficient time to clear residual tumor cells, thereby improving the pathological response. This may explain why the interval between the last surgery in the pCR group was longer than in the non-pCR group in this study. This result is consistent with the NADIM study, where surgery performed 6â€“7 weeks after the last neoadjuvant therapy significantly improved the pCR rate<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>.</p>
<p id="Par32">Differences in Treg cell dynamics between pCR and non-pCR groups, particularly in the T/Treg ratio post-treatment, highlight a valuable indicator of treatment efficacy. These results underscore the importance of a balanced immune environment with regulated Treg activity for achieving pCR. Extensive research has shown that high Treg levels correlate with poorer outcomes in various cancers<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>,<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. Furthermore, a decrease in Treg levels correlates with improved DFS, emphasizing Treg monitoring as a promising biomarker for predicting treatment success and survival in G/GEJ cancer. Modulating Tregs, in conjunction with traditional therapies, may significantly enhance patient survival by boosting antitumor immunity<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>.</p>
<p id="Par33">The complex interplay between Treg cells and cancer treatment efficacy, especially during neoadjuvant chemoimmunotherapy for G/GEJ cancer, situates our research within a critical area of oncological investigation. Our study highlights how Treg dynamics correlate with pCR rates and DFS, offering insights that both align with and expand upon existing literature on the dual role of Treg cells in cancer. These cells are pivotal for maintaining immune tolerance and preventing autoimmunity but can also impair antitumor immune responses. For example, Facciabene et al. emphasized the negative prognostic impact of high Treg infiltration in ovarian cancer, pointing to a need for strategies that modulate Treg levels to improve patient outcomes<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. Similarly, foundational work by Sakaguchi et al. on Treg mechanisms supports their role in promoting tumor growth<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>, and Mao et al. suggested that immune environment manipulation could enhance response to breast cancer therapy<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. Our findings underscore the potential of targeting Tregs to enhance neoadjuvant treatment efficacy in G/GEJ cancers, dovetailing with broader oncological research that seeks to refine immunomodulatory approaches.</p>
<p id="Par34">Comparatively, studies focusing on neoadjuvant immunotherapy in cancers such as melanoma and non-small cell lung cancer have also reported on the predictive value of Treg alterations. A study by van Pul et al. on melanoma patients treated with ipilimumab, a CTLA-4 inhibitor, observed that reductions in peripheral blood Tregs correlated with improved patient outcomes<sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>. This finding parallels our observations in G/GEJ cancer, suggesting a potential universal biomarker across different cancers for predicting response to therapy. Moreover, the work of Pardoll on PD-1/PD-L1 checkpoint inhibitors in treating various cancers emphasizes the intricate balance between activating effective antitumor immunity and regulating immune tolerance<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. Our study aligns with this perspective, showing that Treg cell dynamics can serve as an essential indicator of this balance and thus the efficacy of neoadjuvant chemoimmunotherapy.</p>
<p id="Par35">Recent studies in gastric cancer specifically, such as the one by Li et al., have begun to explore the predictive role of Tregs in response to chemotherapy and immunotherapy, affirming the relevance of our findings to current research trends<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. These studies, however, often focus on the static presence of Tregs pre- and post-treatment, whereas our research contributes a novel angle by examining the dynamic changes in Tregs and their relation to treatment outcomes. Furthermore, the prognostic value of Tregs modulation in enhancing therapy effectiveness is highlighted in the comprehensive review by Tanaka and Sakaguchi, which meticulously outlines the potential therapeutic strategies targeting Treg cells<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. Our research supports this proposed strategy, suggesting that monitoring and potentially modulating Tregs levels could be a viable approach to improving neoadjuvant chemoimmunotherapy outcomes in G/GEJ cancer. By demonstrating the significance of Tregs alterations in the context of chemoimmunotherapy for G/GEJ cancer, our study not only corroborates the critical role of Tregs in cancer progression but also suggests a targeted approach for enhancing treatment responses. Our study contributes to the growing body of literature that explores the complex role of Treg cells in cancer, emphasizing their impact on treatment efficacy and patient outcomes. By detailing the dynamics of Tregs changes in response to neoadjuvant chemoimmunotherapy in G/GEJ cancer and establishing a link to pCR rates and DFS, we offer new insights into the potential of immunomodulatory strategies in oncology. This research not only enriches our understanding of Tregsâ€™ role in cancer therapy but also paves the way for future investigations aimed at harnessing the immune system to combat cancer more effectively.</p>
<p id="Par36">Our study offers important insights into the role of Treg dynamics in the effectiveness of neoadjuvant chemoimmunotherapy for G/GEJ. However, the retrospective design presents limitations that may affect the interpretability and generalizability of our findings. This design restricts our ability to control for confounding variables such as treatment protocol variations and patient comorbidities, potentially introducing bias and impacting the reliability of our conclusions. Additionally, the single-center nature of our study limits the diversity of patient populations and treatment responses, which may not reflect broader healthcare settings. Consequently, our findings may not be universally applicable to all gastric cancer patients undergoing neoadjuvant chemoimmunotherapy. Thirdly, the relatively small sample size further limits our study. A larger cohort is needed to capture the diversity and complexity of gastric cancer and to confirm the robustness of our results. While we observed correlations between Treg dynamics and treatment outcomes, our study does not explore the underlying mechanisms. Understanding the biological pathways through which Tregs affect treatment efficacy is crucial for developing therapeutic strategies. Future research should aim to validate these findings in larger, multicentric studies and conduct mechanistic studies to understand Treg influence on antitumor immunity. Exploring combinatory therapies that target Tregs and enhance effector T cell functions could improve outcomes. The potential of Treg levels as a dynamic biomarker warrants further investigation to refine patient selection and tailor neoadjuvant therapy strategies more effectively.</p>
<p id="Par37">In conclusion, this study sheds light on the dynamic interplay between Tregs and the efficacy of neoadjuvant chemoimmunotherapy in G/GEJ cancer, offering new avenues for research and potential therapeutic interventions. The intricate balance between immune suppression and activation emerges as a critical factor in achieving optimal treatment outcomes, highlighting the importance of immune monitoring and modulation in cancer therapy.</p></section><section id="Sec4"><h2 class="pmc_sec_title">Materials and methods</h2>
<p id="Par38">We conducted this prospective study at the Henan Provincial Cancer Hospital in order to identify serum biomarkers of early response to neoadjuvant chemoimmunotherapy from electronic medical record systems. The trial was conducted in strict adherence to the principles outlined in the Declaration of Helsinki, and the study protocol received approval from the Medical Ethics Committee of Henan Provincial Cancer Hospital (approval number 2021454). Since this is a retrospective study, the ethical committee approved the waiver of informed consent from the patients. A total of 79 patients were included in the study.</p>
<section id="Sec8"><h3 class="pmc_sec_title">Inclusion and exclusion criteria</h3>
<p id="Par40">The Inclusion criteria for this study as follows: (1) Histologically confirmed adenocarcinoma of the stomach or gastroesophageal junction (G/GEJ); (2) Clinically staged as T3-4 or node-positive (N+) without distant metastasis, determined by enhanced computed tomography (CT) (chest, abdomen and pelvis enhanced CT with iopromide contrast, slice thickness 1Â mm) and/or endoscopic ultrasound; (3) Indicated for neoadjuvant therapy by a multidisciplinary team specialized in G/GEJ cancer; (4) Received neoadjuvant therapy comprising chemotherapy and a PD-1 inhibitor; (5) Completed three to four cycles of neoadjuvant chemoimmunotherapy; (6) Underwent curative surgery resulting in R0 resection (no residual microscopic or macroscopic tumor); (7) Had lymphocyte subpopulation analysis conducted before and after the first cycle of neoadjuvant therapy.</p>
<p id="Par41">The exclusion criteria of this study as follows: (1) Presence of distant metastasis; (2) History of other primary malignancies before neoadjuvant therapy initiation; (3) Current use of immunosuppressive agents or corticosteroids exceeding a daily dose of 10Â mg of prednisone or its equivalent; (4) Allergic reaction to chemotherapeutic agents or PD-1 inhibitors during the first cycle of neoadjuvant therapy; (5) Clinically significant cardiovascular or cerebrovascular disease.</p></section><section id="Sec61"><h3 class="pmc_sec_title">Patient treatment and procedure</h3>
<p id="Par43">Patients received neoadjuvant chemotherapy with either the FLOT or CAPOX regimens. The FLOT regimen consisted of docetaxel (50Â mg/mÂ²), oxaliplatin (85Â mg/mÂ²), leucovorin (200Â mg/mÂ²), and 5-fluorouracil (5-FU, 2600Â mg/mÂ² as a 24-hour infusion) on day 1 of each 2-week cycle. The CAPOX regimen included oxaliplatin (130Â mg/mÂ² on day 1) and capecitabine (1000Â mg/mÂ², taken orally twice daily for 14 days), with each cycle lasting 3 weeks. PD-1 inhibitors used included toripalimab and camrelizumab. Surgery was performed 3 to 6 weeks after the final cycle of neoadjuvant therapy. Lymphocyte subset analysis was performed before the first and the second cycle of neoadjuvant therapy. Pathological tumor regression grade (TRG) in the primary tumors was classified according to the Ryan scoring system.</p></section><section id="Sec60"><h3 class="pmc_sec_title">Lymphocyte subgroup analysis</h3>
<ol class="list" style="list-style-type:decimal"><li><p id="Par46">
<em>Quantification of T, B, and NK Cells</em>
</p></li></ol>
<p id="Par47">The steps of quantification of T, B, and NK cells are as follows: (1) Label Absolute Count Tubes (BD Bioscience, Cat. No. 340334) with reagent and sample identifiers; (2) Add 20 ÂµL of the TBNK Mix Antibody (BD Bioscience, Cat. No. 644611) to the mesh at the top of the tube; (3) Add 50 ÂµL of anticoagulated whole blood from the patient above the mesh at the tube wall; (4) Seal the tube with its cap and gently vortex to mix. Incubate in the dark at room temperature (20â€“25Â Â°C) for 15â€“20Â min; (5) Add 450 ÂµL of 1Ã— FACS Lysing Solution (BD Bioscience, Cat. No. 349202) to the tube; (6) Recap the tube and gently vortex to mix. Incubate in the dark at room temperature (20â€“25Â Â°C) for an additional 15Â min; (7) Proceed with flow cytometric analysis.</p>
<ul class="list" style="list-style-type:none"><li>
<span class="label">2)</span><p class="display-inline" id="Par48"><em>Quantification of CD3 + CD4 + and CD3 + CD8 + Cells</em></p>
</li></ul>
<p id="Par49">The steps of quantification of CD3 + CD4 + and CD3 + CD8 + Cells are as follows: (1) Label Absolute Count Tubes (BD Bioscience, Cat. No. 340334) with reagent and sample identifiers; (2) Add 50 ÂµL of anticoagulated whole blood to the tube. Following the antibody manufacturerâ€™s protocol (CD3-FITC, Biolegend, Cat. No. 100203; CD4-APC, Biolegend, Cat. No. 300552; CD8-PerCP, Biolegend, Cat. No. 980916), add the respective fluorochrome-conjugated monoclonal antibodies targeting the cell membrane molecules and incubate in the dark at 4Â Â°C for 20â€“30Â min; (3) Add 2 mL of red blood cell lysis buffer, gently mix by pipetting, and incubate in the dark at room temperature for 10Â min. Centrifuge at 1500Â rpm for 5Â min and discard the supernatant; (4) Resuspend the pellet in 2 mL of PBS, centrifuge at 1500Â rpm for 5Â min, and discard the supernatant; (5) Resuspend the pellet in 500 ÂµL of PBS; (6) Proceed to flow cytometric analysis.</p>
<ul class="list" style="list-style-type:none"><li>
<span class="label">3)</span><p class="display-inline" id="Par50"><em>Treg Cell Enumeration</em></p>
</li></ul>
<p id="Par51">The steps of Treg cell enumeration are as follows: (1) Label flow cytometry tubes and add 100 ÂµL of the blood sample to each tube; (2) Following the antibody manufacturerâ€™s protocol (CD4-FITC, Biolegend, Cat. No. 317410; CD25-PE, Biolegend, Cat. No. 302606; CD127-APC, Biolegend, Cat. No. 351316), add the respective fluorochrome-conjugated monoclonal antibodies targeting the cell membrane molecules and incubate in the dark at 4Â Â°C for 20â€“30Â min; (3) Add 1 mL of red blood cell lysis buffer to each tube, shake, and let stand in the dark at room temperature for 10Â min. Centrifuge at 300Â g for 5Â min and discard the supernatant; (4) Resuspend the cells in 2 mL of 1Ã— PBS, centrifuge at 300Â g for 5Â min, and repeat the washing step once more. Discard the supernatant; (5) Resuspend the cells in 200 ÂµL of PBS and proceed to flow cytometric analysis.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par52">Statistical analysis was performed using GraphPad Prism version 9.0. Continuous variables (age, BMI, albumin, surgery duration, number of lymph nodes detected) were expressed as mean Â± standard deviation. Differences between groups were assessed using the independent samples t-test for normally distributed variables, and the non-parametric Mann-Whitney test for non-normally distributed variables. Categorical variables were compared using the chi-square test or Fisherâ€™s exact test. Disease-free survival (DFS) was defined as the time from surgery to the first observation of recurrence/metastasis, patient death, or last follow-up. Overall survival (OS) was defined as the time from surgery to patient death or last follow-up. Differences in DFS between subgroups were compared using the Log-rank test, with a p-value &lt; 0.05 considered statistically significant.</p></section></section><section id="Sec6"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12332155/bin/41598_2025_14110_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (561.7KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors thank the patients and their families. We also thank the personnel at the study hospitals for their contributions and excellent patient care.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Clinical data and long-term follow-up data were collected under the supervision of Y.Z., C.Z., P.Q., B.M., A.L., F.Z., T.L., L.H., Y.S., Z.W., and L.Z. Y.Z. and C.Z. prepared the initial manuscript draft and edited extensively. All authors have reviewed and contributed to the manuscript writing. P.Q., T.L., and L.H. prepared tables and figures. Statistical review and reporting were provided by Q.G. and L.Z. All authors reviewed the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>The study was supported by grants from the Henan provincial Medical Science and Technology Research Project (LHGJ20210206) and Henan Provincial Scientific and Technological Project (232102310102).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>Data is provided within the manuscript or supplementary information files.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par53">The authors declare no competing interests.</p></section><section id="notes6"><h3 class="pmc_sec_title">Ethical approval</h3>
<p>This study was approved by the Medical Ethics Committee of Henan Cancer Hospital (2021-454). Given the retrospective nature of this study, which involves no interventions and poses minimal risk to participants, informed consent was waived with approval from the ethics committee. This study was also conducted in compliance with the ethical principles outlined in the Declaration of Helsinki.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisherâ€™s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Yong Zhang and Chaoji Zhang contributed equally to this work.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Quanli Gao, Email: gaoquanli2015@126.com.</p>
<p>Lingdi Zhao, Email: lingdi1010@126.com.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. <em>CA Cancer J. Clin.</em><strong>74</strong>(3), 229â€“263. 10.3322/caac.21834 (2024).
</cite> [<a href="https://doi.org/10.3322/caac.21834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38572751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bray,%20F.%20et%20al.%20Global%20cancer%20statistics%202022:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries.%20CA%20Cancer%20J.%20Clin.74(3),%20229%E2%80%93263.%2010.3322/caac.21834%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Siegel, R. L., Giaquinto, A. N. &amp; Jemal, A. Cancer statistics, 2024. <em>CA Cancer J. Clin.</em><strong>74</strong>(1), 12â€“49. 10.3322/caac.21820 (2024).
</cite> [<a href="https://doi.org/10.3322/caac.21820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38230766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Siegel,%20R.%20L.,%20Giaquinto,%20A.%20N.%20&amp;%20Jemal,%20A.%20Cancer%20statistics,%202024.%20CA%20Cancer%20J.%20Clin.74(1),%2012%E2%80%9349.%2010.3322/caac.21820%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Al-Batran, S. E. et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): A randomised, phase 2/3 trial. <em>Lancet</em><strong>393</strong>(10184), 1948â€“1957. 10.1016/S0140-6736(18)32557-1 (2019).
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)32557-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30982686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Al-Batran,%20S.%20E.%20et%20al.%20Perioperative%20chemotherapy%20with%20fluorouracil%20plus%20leucovorin,%20oxaliplatin,%20and%20docetaxel%20versus%20fluorouracil%20or%20capecitabine%20plus%20cisplatin%20and%20epirubicin%20for%20locally%20advanced,%20resectable%20gastric%20or%20gastro-oesophageal%20junction%20adenocarcinoma%20(FLOT4):%20A%20randomised,%20phase%202/3%20trial.%20Lancet393(10184),%201948%E2%80%931957.%2010.1016/S0140-6736(18)32557-1%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Cunningham, D. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. <em>N. Engl. J. Med.</em><strong>355</strong>(1), 11â€“20. 10.1056/NEJMoa055531 (2006).
</cite> [<a href="https://doi.org/10.1056/NEJMoa055531" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16822992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cunningham,%20D.%20et%20al.%20Perioperative%20chemotherapy%20versus%20surgery%20alone%20for%20resectable%20gastroesophageal%20cancer.%20N.%20Engl.%20J.%20Med.355(1),%2011%E2%80%9320.%2010.1056/NEJMoa055531%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Shitara, K. et al. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): An interim analysis of the multicentre, double-blind, randomised phase 3 study. <em>Lancet Oncol.</em><strong>25</strong>(2), 212â€“224. 10.1016/S1470-2045(23)00541-7 (2024).
</cite> [<a href="https://doi.org/10.1016/S1470-2045(23)00541-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38134948/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shitara,%20K.%20et%20al.%20Neoadjuvant%20and%20adjuvant%20pembrolizumab%20plus%20chemotherapy%20in%20locally%20advanced%20gastric%20or%20gastro-oesophageal%20cancer%20(KEYNOTE-585):%20An%20interim%20analysis%20of%20the%20multicentre,%20double-blind,%20randomised%20phase%203%20study.%20Lancet%20Oncol.25(2),%20212%E2%80%93224.%2010.1016/S1470-2045(23)00541-7%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Janjigian, Y. Y. et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): A randomised, open-label, phase 3 trial. <em>Lancet</em><strong>398</strong>(10294), 27â€“40. 10.1016/S0140-6736(21)00797-2 (2021).
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00797-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8436782/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34102137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Janjigian,%20Y.%20Y.%20et%20al.%20First-line%20nivolumab%20plus%20chemotherapy%20versus%20chemotherapy%20alone%20for%20advanced%20gastric,%20gastro-oesophageal%20junction,%20and%20oesophageal%20adenocarcinoma%20(CheckMate%20649):%20A%20randomised,%20open-label,%20phase%203%20trial.%20Lancet398(10294),%2027%E2%80%9340.%2010.1016/S0140-6736(21)00797-2%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Huang, S. et al. Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer. <em>Lung Cancer</em><strong>186</strong>, 107401. 10.1016/j.lungcan.2023.107401 (2023).
</cite> [<a href="https://doi.org/10.1016/j.lungcan.2023.107401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37844351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang,%20S.%20et%20al.%20Evaluation%20of%20combined%20pathological%20responses%20in%20primary%20tumor%20and%20lymph%20nodes%20following%20neoadjuvant%20chemoimmunotherapy%20in%20non-small%20cell%20lung%20cancer.%20Lung%20Cancer186,%20107401.%2010.1016/j.lungcan.2023.107401%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Gambacorta, G. M. A. et al. pCR and 2-Year Disease-Free survival: A combination of the two endpoints as a new classification for locally advanced rectal cancer patients-an updated pooled analysis of eleven international randomized trials. <em>Cancers</em><strong>15</strong>(12), 3209. 10.3390/cancers15123209 (2023).
</cite> [<a href="https://doi.org/10.3390/cancers15123209" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10295980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37370819/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gambacorta,%20G.%20M.%20A.%20et%20al.%20pCR%20and%202-Year%20Disease-Free%20survival:%20A%20combination%20of%20the%20two%20endpoints%20as%20a%20new%20classification%20for%20locally%20advanced%20rectal%20cancer%20patients-an%20updated%20pooled%20analysis%20of%20eleven%20international%20randomized%20trials.%20Cancers15(12),%203209.%2010.3390/cancers15123209%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Guo, F. et al. Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy. <em>Int. J. Clin. Oncol.</em><strong>28</strong>(9), 1158â€“1165. 10.1007/s10147-023-02369-z (2023).
</cite> [<a href="https://doi.org/10.1007/s10147-023-02369-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37318644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo,%20F.%20et%20al.%20Long-term%20survival%20outcome%20of%20locally%20advanced%20gastric%20cancer%20patients%20who%20achieved%20a%20pathological%20complete%20response%20to%20neoadjuvant%20chemotherapy.%20Int.%20J.%20Clin.%20Oncol.28(9),%201158%E2%80%931165.%2010.1007/s10147-023-02369-z%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Sakaguchi, S., Yamaguchi, T., Nomura, T. &amp; Ono, M. Regulatory T cells and immune tolerance. <em>Cell</em><strong>133</strong>(5), 775â€“787. 10.1016/j.cell.2008.05.009 (2008).
</cite> [<a href="https://doi.org/10.1016/j.cell.2008.05.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18510923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sakaguchi,%20S.,%20Yamaguchi,%20T.,%20Nomura,%20T.%20&amp;%20Ono,%20M.%20Regulatory%20T%20cells%20and%20immune%20tolerance.%20Cell133(5),%20775%E2%80%93787.%2010.1016/j.cell.2008.05.009%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Josefowicz, S. Z., Lu, L. F. &amp; Rudensky, A. Y. Regulatory T cells: Mechanisms of differentiation and function. <em>Annu. Rev. Immunol.</em><strong>30</strong>, 531â€“564. 10.1146/annurev.immunol.25.022106.141623 (2012).
</cite> [<a href="https://doi.org/10.1146/annurev.immunol.25.022106.141623" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6066374/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22224781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Josefowicz,%20S.%20Z.,%20Lu,%20L.%20F.%20&amp;%20Rudensky,%20A.%20Y.%20Regulatory%20T%20cells:%20Mechanisms%20of%20differentiation%20and%20function.%20Annu.%20Rev.%20Immunol.30,%20531%E2%80%93564.%2010.1146/annurev.immunol.25.022106.141623%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Whiteside, T. L What are regulatory T cells (Treg) regulating in cancer and why? <em>Semin. Cancer Biol.</em><strong>22</strong>(4), 327â€“334. 10.1016/j.semcancer.2012.03.004 (2012).
</cite> [<a href="https://doi.org/10.1016/j.semcancer.2012.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3385925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22465232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Whiteside,%20T.%20L%20What%20are%20regulatory%20T%20cells%20(Treg)%20regulating%20in%20cancer%20and%20why?%20Semin.%20Cancer%20Biol.22(4),%20327%E2%80%93334.%2010.1016/j.semcancer.2012.03.004%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Facciabene, A., Motz, G. T. &amp; Coukos, G. T-regulatory cells: Key players in tumor immune escape and angiogenesis. <em>Cancer Res.</em><strong>72</strong>(9), 2162â€“2171. 10.1158/0008-5472.CAN-11-3687 (2012).
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-11-3687" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3342842/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22549946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Facciabene,%20A.,%20Motz,%20G.%20T.%20&amp;%20Coukos,%20G.%20T-regulatory%20cells:%20Key%20players%20in%20tumor%20immune%20escape%20and%20angiogenesis.%20Cancer%20Res.72(9),%202162%E2%80%932171.%2010.1158/0008-5472.CAN-11-3687%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Tanaka, A. &amp; Sakaguchi, S. Regulatory T cells in cancer immunotherapy. <em>Cell. Res.</em><strong>27</strong>(1), 109â€“118. 10.1038/cr.2016.151 (2017).
</cite> [<a href="https://doi.org/10.1038/cr.2016.151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5223231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27995907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tanaka,%20A.%20&amp;%20Sakaguchi,%20S.%20Regulatory%20T%20cells%20in%20cancer%20immunotherapy.%20Cell.%20Res.27(1),%20109%E2%80%93118.%2010.1038/cr.2016.151%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Sharma, P. &amp; Allison, A. P. The future of immune checkpoint therapy. <em>Science</em><strong>348</strong>(6230), 56â€“61. 10.1126/science.aaa8172 (2015).
</cite> [<a href="https://doi.org/10.1126/science.aaa8172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25838373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sharma,%20P.%20&amp;%20Allison,%20A.%20P.%20The%20future%20of%20immune%20checkpoint%20therapy.%20Science348(6230),%2056%E2%80%9361.%2010.1126/science.aaa8172%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Xu, J. et al. Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: The ORIENT-16 randomized clinical trial. <em>JAMA</em><strong>330</strong>(21), 2064â€“2074. 10.1001/jama.2023.19918 (2023).
</cite> [<a href="https://doi.org/10.1001/jama.2023.19918" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10698618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38051328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu,%20J.%20et%20al.%20Sintilimab%20plus%20chemotherapy%20for%20unresectable%20gastric%20or%20gastroesophageal%20junction%20cancer:%20The%20ORIENT-16%20randomized%20clinical%20trial.%20JAMA330(21),%202064%E2%80%932074.%2010.1001/jama.2023.19918%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Provencio, M. et al. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): An open-label, multicentre, single-arm, phase 2 trial. <em>Lancet Oncol.</em><strong>21</strong>(11), 1413â€“1422. 10.1016/S1470-2045(20)30453-8 (2020).
</cite> [<a href="https://doi.org/10.1016/S1470-2045(20)30453-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32979984/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Provencio,%20M.%20et%20al.%20Neoadjuvant%20chemotherapy%20and%20nivolumab%20in%20resectable%20non-small-cell%20lung%20cancer%20(NADIM):%20An%20open-label,%20multicentre,%20single-arm,%20phase%202%20trial.%20Lancet%20Oncol.21(11),%201413%E2%80%931422.%2010.1016/S1470-2045(20)30453-8%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Provencio, M. et al. Perioperative nivolumab and chemotherapy in stage III non-small-cell lung cancer. <em>N. Engl. J. Med.</em><strong>389</strong>(6), 504â€“513. 10.1056/NEJMoa2215530 (2023).
</cite> [<a href="https://doi.org/10.1056/NEJMoa2215530" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37379158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Provencio,%20M.%20et%20al.%20Perioperative%20nivolumab%20and%20chemotherapy%20in%20stage%20III%20non-small-cell%20lung%20cancer.%20N.%20Engl.%20J.%20Med.389(6),%20504%E2%80%93513.%2010.1056/NEJMoa2215530%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Mao, Y. et al. The immune phenotypes and different immune escape mechanisms in colorectal cancer. <em>Front. Immunol.</em><strong>13</strong>, 968089. 10.3389/fimmu.2022.968089 (2022).
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.968089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9399611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36032084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mao,%20Y.%20et%20al.%20The%20immune%20phenotypes%20and%20different%20immune%20escape%20mechanisms%20in%20colorectal%20cancer.%20Front.%20Immunol.13,%20968089.%2010.3389/fimmu.2022.968089%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Zagorulya, M. et al. Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer. <em>Immunity</em><strong>56</strong>(2), 386â€“405. 10.1016/j.immuni.2023.01.010 (2023).
</cite> [<a href="https://doi.org/10.1016/j.immuni.2023.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10880816/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36736322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zagorulya,%20M.%20et%20al.%20Tissue-specific%20abundance%20of%20interferon-gamma%20drives%20regulatory%20T%20cells%20to%20restrain%20DC1-mediated%20priming%20of%20cytotoxic%20T%20cells%20against%20lung%20cancer.%20Immunity56(2),%20386%E2%80%93405.%2010.1016/j.immuni.2023.01.010%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Facciabene, A. et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. <em>Nature</em><strong>475</strong>(7355), 226â€“230. 10.1038/nature10169 (2011).
</cite> [<a href="https://doi.org/10.1038/nature10169" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21753853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Facciabene,%20A.%20et%20al.%20Tumour%20hypoxia%20promotes%20tolerance%20and%20angiogenesis%20via%20CCL28%20and%20T(reg)%20cells.%20Nature475(7355),%20226%E2%80%93230.%2010.1038/nature10169%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Mao, X. D., Chen, S. Z., Shen, S. Q. &amp; Liu, K. S. Clinical significance of regulatory T cells and T lymphocyte subsets in peripheral blood in neoadjuvant chemotherapy for breast cancer. <em>Am. J. Cancer Res.</em><strong>13</strong>(7), 3091â€“3099 (2023).
</cite> [<a href="/articles/PMC10408470/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37559980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mao,%20X.%20D.,%20Chen,%20S.%20Z.,%20Shen,%20S.%20Q.%20&amp;%20Liu,%20K.%20S.%20Clinical%20significance%20of%20regulatory%20T%20cells%20and%20T%20lymphocyte%20subsets%20in%20peripheral%20blood%20in%20neoadjuvant%20chemotherapy%20for%20breast%20cancer.%20Am.%20J.%20Cancer%20Res.13(7),%203091%E2%80%933099%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>van Pul, K. M. et al. Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T(reg) reduction and effector T cell activation. <em>Sci. Immunol.</em><strong>7</strong>(73), eabn8097. 10.1126/sciimmunol.abn8097 (2022).
</cite> [<a href="https://doi.org/10.1126/sciimmunol.abn8097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35857579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Pul,%20K.%20M.%20et%20al.%20Local%20delivery%20of%20low-dose%20anti-CTLA-4%20to%20the%20melanoma%20lymphatic%20basin%20leads%20to%20systemic%20T(reg)%20reduction%20and%20effector%20T%20cell%20activation.%20Sci.%20Immunol.7(73),%20eabn8097.%2010.1126/sciimmunol.abn8097%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Pardoll, D. M. The Blockade of immune checkpoints in cancer immunotherapy. <em>Nat. Rev. Cancer</em><strong>12</strong>(4), 252â€“264. 10.1038/nrc3239 (2012).
</cite> [<a href="https://doi.org/10.1038/nrc3239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4856023/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22437870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pardoll,%20D.%20M.%20The%20Blockade%20of%20immune%20checkpoints%20in%20cancer%20immunotherapy.%20Nat.%20Rev.%20Cancer12(4),%20252%E2%80%93264.%2010.1038/nrc3239%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Li, Y. et al. Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer. <em>Theranostics</em><strong>12</strong>(8), 3818â€“3833. 10.7150/thno.71833 (2022).
</cite> [<a href="https://doi.org/10.7150/thno.71833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9131288/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35664061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li,%20Y.%20et%20al.%20Single-cell%20landscape%20reveals%20active%20cell%20subtypes%20and%20their%20interaction%20in%20the%20tumor%20microenvironment%20of%20gastric%20cancer.%20Theranostics12(8),%203818%E2%80%933833.%2010.7150/thno.71833%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12332155/bin/41598_2025_14110_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (561.7KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data is provided within the manuscript or supplementary information files.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41598-025-14110-z"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41598_2025_Article_14110.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.6Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12332155/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12332155/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12332155%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12332155/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12332155/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12332155/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40775000/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12332155/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40775000/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12332155/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12332155/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="lFP7EzbkbraLL3h3xeowpc5be3k1uC20yFGnVGRsJAcxA87wdvvk8y8BbEJQkUJ3">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
